Dev Labtech Venture Limited has announced a board meeting scheduled for March 27, 2026, at 03:00 p.m. to consider several significant corporate restructuring proposals. The meeting will be held at the company's office located at Plot No 53-54, 1st Floor, Thakordwar Society, Mini Bazar, Varachha Road, Surat-395006, Gujarat.

Board Meeting Agenda

The board meeting has been convened under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, to address four major business items that could significantly impact the company's capital structure.

Regulatory Compliance Measures

In accordance with insider trading prevention protocols, Dev Labtech Venture Limited has implemented a trading window closure effective March 19, 2026. This closure aligns with the company's Code of Conduct for Monitoring and Prevention of Insider Trading, adopted in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

The trading window will remain closed until 48 hours after the conclusion of the board meeting on March 27, 2026. This measure ensures compliance with regulatory requirements and prevents any potential insider trading activities during the period of material information consideration.

Corporate Structure Implications

The proposed agenda items represent comprehensive corporate restructuring initiatives. The increase in authorized share capital and MOA amendments would provide the company with enhanced financial flexibility. The share subdivision proposal could improve liquidity by making shares more accessible to retail investors, while the bonus share issuance would reward existing equity shareholders.

All proposed measures are subject to requisite regulatory approvals and shareholder consent where applicable. The company has notified BSE Limited about the board meeting, with the stock trading under scrip code 543848 on the BSE SME platform.

Dev Labtech Venture Limited has completed its initial investment in the Dubai-based wholly-owned subsidiary DEV LABTECH TRADING FZCO, marking a significant step in the company's international expansion strategy. The company made a payment of AED 4,90,000 on March 13, 2026, with confirmation of receipt received on March 14, 2026.

Investment Details

The subscription involves 490 equity shares at AED 1,000 each par value, representing 100% shareholding in the subsidiary. The investment was made entirely through cash consideration, with the company fully subscribing to the share capital of the newly incorporated entity.

Subsidiary Company Profile

DEV LABTECH TRADING FZCO was incorporated on October 29, 2025, in Dubai, UAE, under Certificate of Registration No. DMCC203584 issued by The Registrar of Companies of the Dubai Multi Commodities Centre Authority (DMCCA). The subsidiary operates in the trading of jewellery, diamonds, pearls and precious stones, aligning with the parent company's core business activities.

Strategic Objectives

The acquisition serves multiple strategic purposes for Dev Labtech Venture Limited. The company aims to expand its business operations and establish a global presence while leveraging new growth opportunities in the UAE markets. As a newly incorporated entity, the subsidiary currently has no operational history or turnover.

Regulatory Compliance

The investment constitutes a related party transaction as DEV LABTECH TRADING FZCO is a wholly-owned subsidiary. The company has confirmed that the investment is conducted on an arm's length basis. No specific regulatory approvals were required for this acquisition, as the entity was incorporated pursuant to relevant UAE laws and statutes.

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing comprehensive details of the investment to BSE Limited where its shares are listed on the SME platform.